Trials / Completed
CompletedNCT06891170
B Cell Responses in COVID-19
B Cell Responses in COVID-19: Generation of SARS-CoV-2 Neutralizing Human Monoclonal Antibodies to Efficiently Contrast Wild-type and Emerging Variants.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 4 (actual)
- Sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
In this study, we will develop techniques to optimize the in vitro production of human monoclonal antibodies.
Conditions
Timeline
- Start date
- 2021-07-07
- Primary completion
- 2024-10-14
- Completion
- 2025-03-31
- First posted
- 2025-03-24
- Last updated
- 2025-04-30
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06891170. Inclusion in this directory is not an endorsement.